The immunological role of the pericardial adipose tissue in obesity

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037611

Enrollment

400

Registered

2025-08-19

Start date

2025-09-12

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66

Interventions

Group 1: Patients with obesity (BMI > 30 kg/m2) Molecular biological analyses are performed to characterise differences in the adipose tissue between the two studied groups. Group 2: Control group: Pa

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: BMI > 30 kg/m2 OR BMI < 25 kg/m2

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The goal of this study is to explore the molecular changes of the adipose tissue in the development of obesity.	—

Secondary

Measure	Time frame
Exploratory study, non-applicable	—

Countries

Germany

Contacts

Public ContactStefan Engelhardt

Institut für Pharmakologie und Toxikologie, Technische Universität München

office.pharma.med@tum.de+49 89 4140 3260

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026